PYOTT DAVID E I Insider Trades

Insider Trading History

Track insider trading activity for PYOTT DAVID E I. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $215k 3,837 shares
Last Trade
Jun 25, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$454k 7,060 shares
$64.34
$56.11
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.52M 5,412 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.13M 3,830 shares
$295.63
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $1.26M 4,491 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.15M 3,830 shares
$299.18
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$1.13M 3,830 shares
$295.63
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $445k 1,582 shares
Last Trade
May 20, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$630k 2,112 shares
$298.48
$281.26
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $0 0 shares
Last Trade
Apr 24, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85k 1,383 shares
$61.45
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $77.6k 1,383 shares
Last Trade
Apr 24, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$85k 1,383 shares
$61.45
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $0 0 shares
Last Trade
Feb 18, 2026 Sale
$135k 2,128 shares
$63.27
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $331k 5,893 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$373k 5,893 shares
$63.27
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $0 0 shares
Last Trade
Feb 18, 2026 Sale
$158k 2,500 shares
$63.27
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $0 0 shares
Last Trade
Feb 18, 2026 Sale
$443k 7,000 shares
$63.27
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $0 0 shares
Last Trade
Feb 18, 2026 Sale
$87.5k 1,383 shares
$63.27
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $0 0 shares
Last Trade
Feb 18, 2026 Sale
$158k 2,500 shares
$63.27
$56.11
Tarsus Pharmaceuticals
Tarsus Pharmaceuticals TARS
Director
Holding Value $209k 3,729 shares
Last Trade
Feb 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$236k 3,729 shares
$63.27
$56.11
Pliant Therapeutics
Pliant Therapeutics PLRX
Director
Holding Value $32.7k 30,000 shares
Last Trade
Jun 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$48.3k 30,000 shares
$1.61
$1.09
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $438k 1,558 shares
Last Trade
May 08, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$403k 1,558 shares
$258.35
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $2.13M 7,576 shares
Last Trade
Mar 24, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.16M 7,440 shares
$290.70
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $0 0 shares
Last Trade
Mar 24, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.16M 7,440 shares
$290.70
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $38.3k 136 shares
Last Trade
Mar 24, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.22M 7,440 shares
$299.00
$281.26
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals ALNY
Director
Holding Value $9.17M 32,586 shares
Last Trade
Jun 24, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$7.23M 32,450 shares
$222.90
$281.26

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up